A 2-year placebo-controlled study of orlistat in the treatment of obesity.

被引：0
|
作者：
Lucas, C
机构：
来源：
DIABETES | 1997年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：339 / 339
页数：1
相关论文
共 50 条
  • [21] A 2-YEAR, PLACEBO-CONTROLLED TRIAL OF NONSTEROIDAL ANTIINFLAMMATORY THERAPY IN OSTEOARTHRITIS OF THE KNEE-JOINT
    DIEPPE, P
    CUSHNAGHAN, J
    JASANI, MK
    MCCRAE, F
    WATT, I
    BRITISH JOURNAL OF RHEUMATOLOGY, 1993, 32 (07): : 595 - 600
  • [22] Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study
    Therese F. Nielsen
    Pernille Ravn
    Yu Z. Bagger
    Lise Warming
    Claus Christiansen
    Osteoporosis International, 2004, 15 : 168 - 174
  • [23] Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study
    Nielsen, TF
    Ravn, P
    Bagger, YZ
    Warming, L
    Christiansen, C
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 (02) : 168 - 174
  • [24] Efficacy of acarbose in patients receiving dietary training and counselling - A 2-year placebo-controlled, double-blind study
    Hasche, H
    Mertes, G
    DIABETES, 1998, 47 : A90 - A90
  • [25] Risedronate is safe and effective in men with osteoporosis in a 2-year, double-blind, randomized, placebo-controlled, multicenter study
    Boonen, S.
    Delmas, P. D.
    Wenderoth, D.
    Stoner, K. J.
    Eusebio, R.
    Orwoll, E. S.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S119 - S119
  • [26] Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: A randomised, placebo-controlled study
    Geisler, J.
    Lonning, P. E.
    Krag, L. E.
    Lokkevik, E.
    Risberg, T.
    Hagen, A. I.
    Schlichting, E.
    Lien, E. A.
    Ofjord, E. S.
    Eide, G. E.
    Polli, A.
    di Salle, E.
    Paolini, J.
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (17) : 2968 - 2975
  • [27] Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
    Astrup, Arne
    Rossner, Stephan
    Van Gaal, Luc
    Rissanen, Aila
    Niskanen, Leo
    Al Hakim, Mazin
    Madsen, Jesper
    Rasmussen, Mads F.
    Lean, Michael E. J.
    LANCET, 2009, 374 (9701): : 1606 - 1616
  • [28] Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study
    Boonen, Steven
    Lorenc, Roman S.
    Wenderoth, Dietrich
    Stoner, Karen J.
    Eusebio, Rachelle
    Orwoll, Eric S.
    BONE, 2012, 51 (03) : 383 - 388
  • [29] Cognitive behavioral therapy and orlistat for the treatment of binge eating disorder: A randomized placebo-controlled trial
    Grilo, C
    Masheb, R
    Salant, S
    OBESITY RESEARCH, 2004, 12 : A28 - A28
  • [30] Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy
    Arvidsson, MB
    Löwhagen, O
    Rak, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (05) : 777 - 783
12345